Cargando…
Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia
BACKGROUND: Malaria in Zambia accounts for about 4 million clinical cases and 8 000 deaths annually. Artemether-lumefantrine (ACT), a relatively expensive drug, is being used as first line treatment of uncomplicated malaria. However, diagnostic capacity in Zambia is low, leading to potentially avoid...
Autores principales: | Chanda, Pascalina, Castillo-Riquelme, Marianela, Masiye, Felix |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676244/ https://www.ncbi.nlm.nih.gov/pubmed/19356225 http://dx.doi.org/10.1186/1478-7547-7-5 |
Ejemplares similares
-
A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
por: Chanda, Pascalina, et al.
Publicado: (2007) -
Health Seeking Behaviour among Individuals with Presumptive Tuberculosis in Zambia
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2016) -
Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management
por: Chanda, Pascalina, et al.
Publicado: (2011) -
The adult prevalence of HIV in Zambia: results from a population based mobile testing survey conducted in 2013–2014
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2016) -
Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia
por: Barnes, Karen I, et al.
Publicado: (2009)